| SERENITY PHARMACEUTICALS CORPORATION Patent applications |
| Patent application number | Title | Published |
|---|
| 20100160214 | DESMOPRESSIN COMPOSITION - Disclosed is a pharmaceutical formulation that may be used in the treatment of nocturia, primary nocturnal enuresis, incontinence, urinary frequency, diabetes insipidus, or any disease or syndrome where desmopressin therapy is useful or where safe temporary suppression of urine production may lead to beneficial health effects or increased convenience in voiding control. | 06-24-2010 |
| 20090042970 | METHODS AND DEVICES FOR DESMOPRESSIN DRUG DELIVERY - Disclosed are devices for urine voiding postponement, and methods for treating conditions such as central diabetes insipidus, enuresis, nocturia, urinary frequency or incontinence. The devices deliver a desmopressin flux through the skin of a patient in a low dose amount just necessary to achieve a desired anti-diuretic effect without undesirable side effects such as hyponatremia. The devices are designed to permit a state of normal urinary production to return quickly after the desmopressin flux is terminated. | 02-12-2009 |
